Chatbot aims to spot hidden cancer risk in routine doctor visits
NCT ID NCT07130487
Summary
This study is testing whether a digital chatbot can help identify patients at high risk for hereditary cancers during routine primary care visits. Researchers will invite 210 patients to use the chatbot for a cancer risk assessment. The main goal is to see how many patients complete the assessment, how many are flagged as high risk, and how many of those high-risk patients follow up with genetic counseling or testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY CARE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rutgers, The State University of New Jersey
RECRUITINGNew Brunswick, New Jersey, 08901, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.